PET-guided omission of radiotherapy in Hodgkin lymphoma - Authors' reply

Peter Borchmann¹, Annette Plütschow², Helen Görgen²

Affiliations

¹ Department I of Internal Medicine, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf; German Hodgkin Study Group, Faculty of Medicine and University of Cologne, Cologne 50924, Germany. Electronic address: peter.borchmann@uk-koeln.de.
² Department I of Internal Medicine, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf.

PMID: 33932379
DOI: 10.1016/S1470-2045(21)00210-2

Comment

PET-guided omission of radiotherapy in Hodgkin lymphoma - Authors' reply

Peter Borchmann et al. Lancet Oncol. 2021 May.

. 2021 May;22(5):e182.

doi: 10.1016/S1470-2045(21)00210-2.

Authors

Peter Borchmann¹, Annette Plütschow², Helen Görgen²

Affiliations

¹ Department I of Internal Medicine, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf; German Hodgkin Study Group, Faculty of Medicine and University of Cologne, Cologne 50924, Germany. Electronic address: peter.borchmann@uk-koeln.de.
² Department I of Internal Medicine, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf.

PMID: 33932379
DOI: 10.1016/S1470-2045(21)00210-2

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Borchmann P, Plütschow A, Kobe C, Greil R, Meissner J, Topp MS, Ostermann H, Dierlamm J, Mohm J, Thiemer J, Sökler M, Kerkhoff A, Ahlborn M, Halbsguth TV, Martin S, Keller U, Balabanov S, Pabst T, Vogelhuber M, Hüttmann A, Wilhelm M, Zijlstra JM, Moccia A, Kuhnert G, Bröckelmann PJ, von Tresckow B, Fuchs M, Klimm B, Rosenwald A, Eich H, Baues C, Marnitz S, Hallek M, Diehl V, Dietlein M, Engert A. Borchmann P, et al. Lancet Oncol. 2021 Feb;22(2):223-234. doi: 10.1016/S1470-2045(20)30601-X. Lancet Oncol. 2021. PMID: 33539742 Clinical Trial.
PET-guided omission of radiotherapy in Hodgkin lymphoma.
Shibusawa M, Kidoguchi K, Mori J, Tanimoto T. Shibusawa M, et al. Lancet Oncol. 2021 May;22(5):e181. doi: 10.1016/S1470-2045(21)00146-7. Lancet Oncol. 2021. PMID: 33932378 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

PET-guided omission of radiotherapy in Hodgkin lymphoma - Authors' reply

Affiliations

PET-guided omission of radiotherapy in Hodgkin lymphoma - Authors' reply

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical